Seasoned C‑suite executive and qualified pharmacist with a strategic vision spanning biotechnology, MedTech, and pharma. He excels in orchestrating high-value growth—closing over 120 partnership and licensing deals exceeding USD 1 billion—and transforming organizations through robust business development, project management, and licensing operations.

With a PharmD from the University of Siena and a PhD from Cambridge, Marco leverages his academic foundation to guide R&D, manufacturing, clinical, and commercial strategies worldwide. His global insight and operational leadership have driven companies toward market readiness, sustainable success, and new industry benchmarks. He has been instrumental in forging partnerships with life sciences leaders, positioning chAIron to maximize its impact on patient outcomes and market opportunity.